Other
Restructuring charges, separation costs, and other (Note 4)
Edwards Lifesciences Restructuring charges, separation costs, and other (Note 4) remained flat by 0.0% to $4.78M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 68.7%, from $15.25M to $4.78M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ1 2023
Last reportedQ4 2025Feb 25, 2026
How to read this metric
High restructuring costs may signal a transition phase or efforts to improve long-term efficiency, though they negatively impact short-term earnings.
Detailed definition
These charges encompass costs associated with organizational restructuring, corporate separation activities, or other no...
Peer comparison
Commonly reported as non-GAAP adjustments by companies undergoing strategic shifts.
Metric ID:
other_restructuring_charges_separation_costs_and_other_expensesHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $0.00 | $61.00M | $19.10M |
| YoY Change | — | — | -68.7% |
Range$0.00 – $61.00M
Avg YoY Growth-68.7%
Median YoY Growth-68.7%
Restructuring charges, separation costs, and other (Note 4) at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's restructuring charges, separation costs, and other (note 4)?
- Edwards Lifesciences (EW) reported restructuring charges, separation costs, and other (note 4) of $4.78M in Q4 2025.
- How has Edwards Lifesciences's restructuring charges, separation costs, and other (note 4) changed year-over-year?
- Edwards Lifesciences's restructuring charges, separation costs, and other (note 4) decreased by 68.7% year-over-year, from $15.25M to $4.78M.
- What does restructuring charges, separation costs, and other (note 4) mean?
- One-time costs related to reorganizing the company or spinning off business units.